USP8 and adenoma: The following paragraphs focus on the reported driver mutations and their pathophysiological consequences, ordered by prevalence, although the estimated prevalence may be biased by the different methods used in molecular studies (i.e., analysis of specific target genes as opposed to tumoral DNA Next Generation Sequencing; inclusion of USP8-WT adenomas only) [38].